Shikiar Asset Management Inc Intra Cellular Therapies, Inc. Transaction History

Shikiar Asset Management Inc

  • $355 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$46.37 - $73.65 $162,295 - $257,775
3,500 New
3,500 $251,000
Q2 2023

Jul 20, 2023
BUY
$54.67 - $66.44 $191,345 - $232,540
3,500 New
3,500 $221,000
Q2 2022

Jul 15, 2022
SELL
$43.0 - $65.64 $150,500 - $229,740
-3,500 Closed
0 $0
Q1 2022

Apr 13, 2022
BUY
$38.74 - $62.09 $135,590 - $217,315
3,500 New
3,500 $214,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Shikiar Asset Management Inc Portfolio

Follow Shikiar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email